Search - tctmd.com

Displaying 61 - 74 of 74

Sort: Relevancy | Date

News Industry News

Cardiac Ablation Technology will be Featured during Scientific Sessions and Academic Symposium

August 22, 2012

News Industry News

Arterial Remodeling Technologies (ART) reports first human use of its next-generation bioresorbable stent

July 16, 2012

News Industry News

ART receives receives regulatory approval to begin First-In-Man “ARTDIVA” clinical trial with its next-generation bioresorbable stent

May 15, 2012

News Industry News

Abbott's XIENCE PRIME™ and XIENCE V® Drug Eluting Stents Receive Indication in Europe for Minimum Three-Month Duration of Dual Anti-Platelet Therapy

May 15, 2012

News Industry News

Regado Biosciences, Inc. Presents Positive Efficacy and Safety Substudy Data from the Phase 2b RADAR Trial for the REG1 Anticoagulation System

November 06, 2011

News Industry News

Volcano Corporation Announces Upcoming Presentation of Late-Breaking Clinical Trial Results and FFR Product Launch at TCT 2011

November 04, 2011

News Industry News

Arterial Remodeling Technologies (“ART”) reports that its second-generation bioresorbable stent promotes vessel lumen enlargement in post-angioplasty in vivo model

November 02, 2011

News Industry News

Medtronic Starts Landmark Study of Hypertension Treatment

October 26, 2011

News Industry News

Medtronic Gets Go-Ahead from FDA for Study of Novel Treatment for High Blood Pressure

July 11, 2011

News Industry News

St. Jude Medical to Showcase PCI Optimization Technology and Structural Heart Portfolio at EuroPCR

May 16, 2011

News Industry News

St. Jude Medical Sponsored Study Determines FFR Can Improve Health while Reducing Economic Burden to German Healthcare System

April 29, 2011

News Industry News

Boston Scientific Launches PROMUS® Element™ and TAXUS® Element™ Stent Systems in India

February 16, 2011

News Industry News

Vascular Solutions introduces the SmartNeedle® Vascular Access System

January 09, 2011

News Industry News

Bayer’s Rivaroxaban Submitted for EU Marketing Authorisation in Stroke Prevention in Patients with Atrial Fibrillation as well as for the Treatment of Deep Vein Thrombosis

January 04, 2011

Advertisement

Cardiac Ablation Technology will be Featured during Scientific Sessions and Academic Symposium

Arterial Remodeling Technologies (ART) reports first human use of its next-generation bioresorbable stent

ART receives receives regulatory approval to begin First-In-Man “ARTDIVA” clinical trial with its next-generation bioresorbable stent

Abbott's XIENCE PRIME™ and XIENCE V® Drug Eluting Stents Receive Indication in Europe for Minimum Three-Month Duration of Dual Anti-Platelet Therapy

Regado Biosciences, Inc. Presents Positive Efficacy and Safety Substudy Data from the Phase 2b RADAR Trial for the REG1 Anticoagulation System

Volcano Corporation Announces Upcoming Presentation of Late-Breaking Clinical Trial Results and FFR Product Launch at TCT 2011

Arterial Remodeling Technologies (“ART”) reports that its second-generation bioresorbable stent promotes vessel lumen enlargement in post-angioplasty in vivo model

Medtronic Starts Landmark Study of Hypertension Treatment

Medtronic Gets Go-Ahead from FDA for Study of Novel Treatment for High Blood Pressure

St. Jude Medical to Showcase PCI Optimization Technology and Structural Heart Portfolio at EuroPCR

St. Jude Medical Sponsored Study Determines FFR Can Improve Health while Reducing Economic Burden to German Healthcare System

Boston Scientific Launches PROMUS® Element™ and TAXUS® Element™ Stent Systems in India

Vascular Solutions introduces the SmartNeedle® Vascular Access System

Bayer’s Rivaroxaban Submitted for EU Marketing Authorisation in Stroke Prevention in Patients with Atrial Fibrillation as well as for the Treatment of Deep Vein Thrombosis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content